SHINNIHONSEIYAKU CO., LTD. · 新日本製薬株式会社
Ownership & governance
Executives 3Directors 8Avg age 56Avg tenure 6.3y
TG
Takahiro Goto
Chief Executive Officer
Age 55Since 2021-11-30
+10
Executives3
TG
Takahiro Goto
Chief Executive Officer
Age 55Since 2021-11-30
MF
Mitsuyoshi Fukuhara
Chief Operating Officer
Age 54—
HI
Higuchi Ichimitsu
Corporate Officer/Principal
——
Board of directors8
TG
Takahiro Goto
Director/Board Member
Age 55Since 2005-11-30
MF
Mitsuyoshi Fukuhara
Director/Board Member
Age 54Since 2016-11-30
SY
Sachiyo Yasuda
Director/Board Member
—Since 2023-12-18
KZ
Keiichi Zenmyo
Director/Board Member
—Since 2023-12-18
TT
Takashi Tanabe
Director/Board Member
—Since 2023-12-18
YN
Yuji Nakanishi
Director/Board Member
Age 65Since 2023-12-18
AM
Asako Minamitani
Director/Board Member
Age 50Since 2024-12-18
YY
Yukiyo Yasuda
Director/Board Member
——
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Eijiro Yamada | 18.77 % | 4,101,500 |
| Laprise KK | 13.64 % | 2,980,600 |
| Emi Yamada | 13.4 % | 2,929,000 |
| Shinnihon Senshin Iryo Kenkyu Zaidan | 7.958 % | 1,739,200 |
| Takahiro Goto | 3.88 % | 847,999 |
Catalog · 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 2,190Range 2,190–2,190Analysts 1
- Hold 1
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.